Morristown, New Jersey-based ingredient supplier PLT Health Solutions, Inc. is launching its new formulation of Zynamite, an ingredient developed to help improve sports performance within one hour after administering a single dose.
 
Zynamite PX, a combination of mangifera indica extract and sophora japonica extract, standardized to 50% quercetin, offers a unique set of benefits in active/sports nutrition products. Multiple clinical trials suggest that Zynamite PX improves peak power output while reducing lactate buildup and speeding recovery from long, intense workouts. Zynamite’s original formula was introduced in 2018, and garnered several yearly awards in Europe and Asia under sports ingredient categories.
 
“In 2020, PLT will introduce multiple, exciting, science-backed ingredients to the active/sports market,” Devin Stagg, CEO of PLT Health Solutions, said. “We want these ingredients to ‘move the needle’ in terms of the type of performance and health benefits consumers can expect. Zynamite PX is one of these with a unique value proposition – it can improve peak power after a single dose in as little as one hour.
 
“Fast-acting and experiential, Zynamite PX is an ideal ingredient for pre-workout formulations – and can also be effective in post-workout recovery-type products,” Stagg continued. “Studies on Zynamite PX also support its use in extreme and endurance sports performance formulations.”
 
A double-blind, cross-over clinical study was conducted in 2018 to determine whether a single 420 mg dose of Zynamite PX administered one hour before exercise would increase repeated-sprint performance. Subjects performed three Wingate tests interspaced by 4 minutes and a final 15 second sprint after ischemia. Peak power was improved by 3.8% in one hour versus placebo in subjects using just one dose of Zynamite PX. One interesting result was that the quercetin dose was about seven times lower than that associated with quercetin ergogenic effects in previous studies, suggesting that this combination may have synergistic effects. 
 
In a second study, designed to evaluate athletic recovery, 48 subjects participated in a 10k race followed by 100 drop jumps from a two-foot height to elicit exercise-induced muscle damage (EIMD). Participants took four doses of either Zynamite PX or a placebo over 25 hours. The experimental group took a single 420 mg dose of Zynamite PX one hour before competition, followed by three additional doses every eight hours. Those who took Zynamite PX had reduced soreness and accelerated recovery of muscle performance compared to those who took placebo.
 
“An increase in peak power of 3.8% might not seem impressive at first, but it’s important to remember that we’re comparing it to other studies where power results were achieved after much longer periods of supplementation,” Jeremy Appleton, ND, director of medical and scientific affairs at PLT, said. “And these endpoints were achieved after training, whereas Zynamite PX had an immediate, demonstrable effect. The same holds true for the recovery benefits associated with Zynamite PX. Taking Zynamite PX just four times in 25 hours produced significant improvement in soreness and ability to exercise compared to placebo. This offers a new type of benefit package to sports nutrition formulators we have not seen before.”